cobimetinib

Ukraine

Drugs containing this active substance

  • COTELLIK

    The drug is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring a BRAF V600 mutation, in combination with vemurafenib.

    Form: tablets, film-coated

    Active substance Dosage
    cobimetinib 20 mg

    ATC: L01EE02

    Manufacturer: F. Hoffmann-La Roche (manufacturing unpackaged products, quality control testing at release (microbiological purity); batch release)